Syncrosome is a preclinical CRO dedicated to In vivo pharmacology since 12 years now and with a strong competency in Efficacy and Pharmacokinetics.
One of our departments is dedicated to Respiratory. We performed in vivo efficacy models in Asthma, Chronic Obstruction Pulmonary Diseases, Cough, Pulmonary Fibrosis and Pulmonary Arterial Hypertension.
Vincent Girod, Head of Pharmacology, will present our skills in this thematic during ERS (European Respiratory Society) congress, in Vienna...
GDDIF Congress: Global Discovery to Development Innovation Leaders Summit 7th & 8th March 2011.
You have several reasons to come and visit us during GDDIF Congress (7th & 8th of March) in London:
- new strategies on preclinical development and discovery will be discussed.
- to assist to a conference on " In vivo models to select your leads " performed by Vincent Girod, Head of In vivo pharmacology in Syncrosome the 7th of March at 11:15 on the main room. Relevance of in v...
Syncrosome is a Preclinical Drug Evaluation Company specialised in human and animal health in vivo pharmacological studies. Syncrosome has the professional expertise to complete studies independently or to work in parallel with in-house research teams, after preliminary in vitro screenings - www.syncrosome.com